Please login to the form below

Not currently logged in


This page shows the latest HPV news and features for those working in and with pharma, biotech and healthcare.

Analysts look beyond Keytruda in Merck’s future

Analysts look beyond Keytruda in Merck’s future

Human papillomavirus (HPV) vaccine Gardasil was up a third to $835m, and there were good performances for cancer drugs Lynparza (olaparib) and Lenvima (lenvatinib), partnered with AstraZeneca and Eisai, respectively.

Latest news

More from news
Approximately 5 fully matching, plus 89 partially matching documents found.

Latest Intelligence

  • 2019: CRISPR and therapeutic gene editing comes of age 2019: CRISPR and therapeutic gene editing comes of age

    The approach is however also set to be tested as an in vivo therapy for cervical cancer caused by human papillomavirus (HPV) by researchers in China, who are comparing a TALEN

  • Advancing women in healthcare Advancing women in healthcare

    She is especially proud of working to reduce the manufacturing costs of vaccines for diseases like human papillomavirus (HPV) and rotavirus, with the aim of these being more widely available in

  • Immunisation politicised Immunisation politicised

    Many countries objected to the HPV vaccine yet the vaccine was introduced rather rapidly in most countries. ... to do so, Austria became a 'European frontrunner' in gender-neutral HPV vaccination.

  • Deal Watch December 2015 Deal Watch December 2015

    200. Bavarian Nordic (DK). Janssen. Collaboration, licence. Vaccine platform technology for development of treatment for cancers induced by HPV.

  • Pharma deals in August 2015 Pharma deals in August 2015

    virus. INO-3112 generates killer T-cell responses to HPV 16 and 18 driven tumours and is in phase I / II clinical studies for cervical and head and neck cancers.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

Measures for measures
Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...